ALB

Albemarle Corporation

Basic Materials
120.78 up +1.32 +1.10% Market Closed (Weekend)
2026-07-17 • USD

Key Metrics

Market Cap 14.24B
EV 15.16B
Shares Out 117.93M
Revenue (ttm) 5.49B
Net Income -232.88M
Beta
P/E
Forward P/E
EPS (ttm) $-3.42
P/S 2.59
P/B 1.45
P/FCF 24.66
P/C 13.14
EV/Sales 2.76
EV/EBITDA 30.24
ROA -1.54%
ROE -2.29%
ROIC -2.14%
Gross Margin 18.44%
Oper. Margin -2.79%
Profit Margin -4.24%
Debt/Eq 0.20
LT Debt/Cap 15.5%
Quick Ratio 1.02
Current Ratio 2.07
Book/sh 83.58
Cash/sh 9.25
Div Yield 1.34%
Div TTM $1.62
Payout Ratio 81.84%
SMA20 -10.27%
SMA50 -24.03%
SMA200 -20.1%
Volume 2,286,461
Avg Volume 2.16M
Rel Volume 1.06
Perf Week -3.98%
Perf Month -24.68%
Perf Quarter -38.01%
Perf Half Y -30.00%
Perf YTD -14.61%
Perf Year 56.71%
Perf 3Y -45.87%
Perf 5Y -35.50%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.4050
TTM Yield 1.34%
TTM Amount $1.62
Payout Ratio 81.84%
3-Yr Growth (CAGR) 0.84%
5-Yr Growth (CAGR) 1.02%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.4050
Q4 2025 ~2025-12-30 $0.4050
Q3 2025 ~2025-09-30 $0.4050
Q2 2025 ~2025-06-30 $0.4050
Q1 2025 ~2025-03-31 $0.4050
Q4 2024 ~2024-12-30 $0.4050
Q3 2024 ~2024-09-30 $0.4050
Q2 2024 ~2024-06-30 $0.4000
Q1 2024 ~2024-03-31 $0.4000
Q4 2023 ~2023-12-30 $0.4000
Q3 2023 ~2023-09-30 $0.4000
Q2 2023 ~2023-06-30 $0.4000

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Albemarle Corporation is a global leader in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The company operates through

Name
Albemarle Corporation
Industry
Specialty Chemicals
CEO
J. Kent Masters, Jr. · Chairman and Chief Executive Officer
Employees
IPO Date
2014-02-28
Phone
(980) 299-5700
Address
4250 Congress Street, Suite 900, Charlotte, NC 28209
Website
www.albemarle.com

Key Executives

Name Title FY Pay
Ander C. Krupa Senior Vice President, General Counsel and Corporate Secretary
J. Kent Masters, Jr. Chairman and Chief Executive Officer

Latest News